Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Efficacy of Double Antithrombotic Therapy With Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta‐Analysis
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume -, Issue -, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-08-01
DOI
10.1161/jaha.120.017212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2020) Renato D. Lopes et al. JAMA Cardiology
- Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study
- (2019) Nienke van Rein et al. CIRCULATION
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey
- (2019) Deirdre A Lane et al. EUROPACE
- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. CIRCULATION
- Frequentist versus Bayesian approaches to multiple testing
- (2019) Arvid Sjölander et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention
- (2019) Xiaofei Gao et al. International Heart Journal
- Indirect comparison of novel Oral anticoagulants among Asians with non-Valvular atrial fibrillation in the real world setting: a network meta-analysis
- (2019) Jianchao Zhang et al. BMC Cardiovascular Disorders
- Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention
- (2019) Joo-Yong Hahn et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
- (2019) Hirotoshi Watanabe et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI
- (2019) Davide Capodanno et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2019) Renato D. Lopes et al. JAMA Cardiology
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
- (2019) Pascal Vranckx et al. LANCET
- Ticagrelor with or without Aspirin in High-Risk Patients after PCI
- (2019) Roxana Mehran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial
- (2019) Renato D. Lopes et al. CIRCULATION
- Intracranial haemorrhages vs. stent thromboses with direct oral anticoagulant plus single antiplatelet agent or triple antithrombotic therapy: a meta-analysis of randomized trials in atrial fibrillation and percutaneous coronary intervention/acute coronary syndrome patients
- (2019) Mattia Galli et al. EUROPACE
- Double or triple antithrombotic therapy after coronary stenting and atrial fibrillation: A systematic review and meta-analysis of randomized clinical trials
- (2019) Giuseppe Andò et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients
- (2019) Angelo Silverio et al. European Heart Journal-Cardiovascular Pharmacotherapy
- Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
- (2018) Harsh B Golwala et al. EUROPEAN HEART JOURNAL
- Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update
- (2018) Davide Capodanno HEART
- A systematic review of network meta-analyses among patients with nonvalvular atrial fibrillation: A comparison of efficacy and safety following treatment with direct oral anticoagulants
- (2018) A.T. Cohen et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention
- (2018) Dominick J. Angiolillo et al. CIRCULATION
- 2018 ESC/EACTS Guidelines on myocardial revascularization
- (2018) Franz-Josef Neumann et al. EUROPEAN HEART JOURNAL
- TCT-775 A Systematic Review of Randomized and Non-randomized Studies Comparing Dual Therapy with Triple Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- (2018) Alexander Sullivan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
- (2018) Pascal Vranckx et al. LANCET
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease
- (2017) Manesh R. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antithrombotic therapy after transcatheter aortic valve implantation: a new piece of the still unresolved puzzle
- (2017) Giuseppe Gargiulo et al. Journal of Thoracic Disease
- Non-factorial analyses of two-by-two factorial trial designs
- (2016) Edward L Korn et al. Clinical Trials
- Radial Access Reduces Mortality in Patients With Acute Coronary Syndromes
- (2016) Giuseppe Andò et al. JACC-Cardiovascular Interventions
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
- (2015) Brian Hutton et al. ANNALS OF INTERNAL MEDICINE
- Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation
- (2015) Katrin A. Fiedler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triple antithrombotic therapy in atrial fibrillation patients with acute coronary syndromes or undergoing percutaneous coronary intervention or transcatheter aortic valve replacement
- (2015) Davide Capodanno et al. EuroIntervention
- Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial
- (2013) Willem JM Dewilde et al. LANCET
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
- (2012) Patricia Guyot et al. BMC Medical Research Methodology
- Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation
- (2012) William L. Baker et al.
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
- (2010) Georgia Salanti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
- (2008) Kristian Thorlund et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
- (2008) Jesper Brok et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
- (2007) Jørn Wetterslev et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started